Purified amniotic membrane compositions and methods of use
AssigneeTissue Tech, Inc.
InventorsScheffer Tseng, Hua He, Wei Li
Life of this patent
Estimating the term…
Loading patent…
AssigneeTissue Tech, Inc.
InventorsScheffer Tseng, Hua He, Wei Li
Estimating the term…
Compositions having a combination of specific biological components have been found to exert a number of useful effects in mammalian cells, including modulating TGF β signaling, apoptosis, and proliferation of mammalian cells, as well as decreasing inflammation in mice. These components can be obtained commercially, or can be prepared from biological tissues such as placental tissues. Placental amniotic membrane (AM) preparations described herein include AM pieces, AM extracts, AM jelly, AM stroma, and mixtures of these compositions with additional components. The compositions can be used to treat various diseases, such as wound healing, inflammation and angiogenesis-related diseases.
1-10. (canceled)
A pharmaceutical composition comprising:
The composition of claim 15, wherein the composition is formulated as an intraocular injection, subretinal injection, intravitreal injection, periocular administration, subconjuctival injection, retrobulbar injection, intracameral injection, sub-Tenon's injection, implant, ophthalmic solution, ophthalmic suspension, ophthalmic ointment, ocular implant, ocular insert, or intraocular solution.
(canceled)
(canceled)
Dependencies are inferred from the claim text.